This announcement is a separate document:
健友股份关于实施权益分派时“健友转债”转股连续停牌的提示性公告
Nanjing King-Friend Biochemical Pharmaceutical hereby issues a notice regarding the suspension of consecutive trading of the "King-Friend Convertible Bond" during the implementation of equity distribution.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.